$8.980
+0.485 (+5.40%)終値時点
ETRA の同業比較
In the context of the broader market, ETRA competes directly with industry leaders such as ACRS and DBVT. With a market capitalization of $548.68M, it holds a significant position in the sector. When comparing efficiency, ETRA's gross margin of N/A stands against ACRS's 10.80% and DBVT's 100.00%. Such benchmarking helps identify whether Electra Therapeutics, Inc. is trading at a premium or discount relative to its financial performance.
Electra Therapeutics, Inc. Common stock の財務パフォーマンス
Electra Therapeutics has a price-to-book ratio of -21.688, indicating negative equity, and both its PE and forward PE ratios are 0, suggesting no earnings are currently being generated.
Financials
No data
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。